Organon & Co. (OGN) CEO Kevin Ali on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
Organon & Co. (OGN)
Company Research
Source: Seeking Alpha
Organon & Co. (NYSE:OGNCompany ParticipantsJennifer Halchak - Vice President, Investor RelationsKevin Ali - Chief Executive OfficerMatt Walsh - Chief Financial OfficerSandra Milligan - Head, R&DConference Call ParticipantsJason Gerberry - Bank of AmericaUmer Raffat - EvercoreDavid Amsellem - Piper SandlerGreg Fraser - Truist SecuritiesOperatorLadies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Organon Second Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. Thank you. I would now like to turn the call over to Jennifer Halchak, Vice President of Investor Relations. Please begin your conference.Thank you, Chantel and good morning everyone. Thank you for joining Organonâ??s second quarter 2022 earnings call. With me today are Kevin Ali, Organonâ??s Chief Executive Officer, who will cover strategy and operational highlights; and Matt Walsh, our Chief Financial Officer, who will review p
Show less
Read more
Impact Snapshot
Event Time:
OGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OGN alerts
High impacting Organon & Co. news events
Weekly update
A roundup of the hottest topics
OGN
News
- Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Organon (OGN) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Why the Market Dipped But Organon (OGN) Gained Today [Yahoo! Finance]Yahoo! Finance
- Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024Business Wire
- Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary EndpointsBusiness Wire
OGN
Earnings
- 2/15/24 - Beat
OGN
Sec Filings
- 4/16/24 - Form 4
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- OGN's page on the SEC website